AMRX Financials
Amneal Pharmaceuticals Inc - Financial statements & key metrics
Stock Price
$13.09
Market Cap
$4.16B
P/E Ratio
59.3
EPS
$0.22
Income Statement Highlights
Most Recent Quarter: 2024-12-31
Revenue
$2.79B
Gross Profit
-
Operating Income
-
Net Income
$-73.88M
EPS (Diluted)
$-0.38
Balance Sheet Highlights
Total Assets
$3.50B
Total Liabilities
-
Shareholders Equity
-
Cash & Equivalents
$110.55M
Total Debt
-
Cash Flow Highlights
Operating Cash Flow
$295.10M
CapEx
-
Free Cash Flow
-
Profitability Metrics
Gross Margin
37.4%
Operating Margin
0.1%
Net Margin
0.0%
ROE
-8.8%
View Complete Financial Statements
Full income statements, balance sheets, and cash flows for multiple periods
Open Full FinancialsFrequently Asked Questions
What is AMRX revenue?
AMRX's most recent quarterly revenue was $2.79B. Annual revenue can be calculated by summing the four most recent quarters.
Is AMRX profitable?
AMRX reported a loss of $73.88M in the most recent quarter. The net profit margin is 0.0%.
What is AMRX market cap?
AMRX has a market capitalization of $4.16B, making it a mid-cap stock.
Does AMRX have debt?
View AMRX's balance sheet for debt information.
What is AMRX cash flow?
Cash flow data is available in the full financial statements.